+91-8668442535

Scar Treatment Market By Treatment Type (Topical Medication, Laser Treatment Cosmetic Treatment, Surgical Treatment, Injectable Treatment) , By Scar Type (Atrophic Scar, Keloid Scar Hypertrophic Scar, Contracture), By End-User Type (Hospital, Private Clinics, Drug Store/Retail Store, E-Commerce) - Growth, Future Prospects, And Competitive Analysis, 2017 - 2025

A scar is formed on the surface of the skin after any damage or injury, which can be removed by applying a variety of medical technologies, from invasive surgical treatment to non-invasive laser treatment or some topical medications. Scars are mostly caused by the body's own healing mechanism; smaller scars can heal on their own given enough time. Any type of invasive surgical procedure, injury, or burn gives rise to a scar on the skin of varying degrees. The treatment is dependent on the scar shape, size, appearance, and degree of growth underneath the skin. According to one study, approximately 100 million patients worldwide develop scars each year, and this growing number, along with the rising trend of accidents and surgical procedures, positively influences the scar treatment market.

The purpose of this research study titled "Scar Treatment Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global scar treatment market. This report presents and analyses the major trends prevalent in the global scar treatment market and provides market size and forecast.

The rising incidence of skin problems, rising number of surgical procedures, rising adoption of technologically advanced procedures and products, rising healthcare expenditure for R&D to manufacture newer and innovative products, government approval on medical products, and rising public awareness to improve physical appearance are some of the major drivers of the scar treatment market; however, the high cost of treatment and adverse effects caused by scar treatment are some of the major restraints.This report categorizes the global scar treatment market in terms of scar type, treatment type, end-user type, and geographical distribution.

On the basis of scar types, the scar treatment market can be segmented as follows:

  • Atrophic Scars
  • Keloid Scars
  • Hypertrophic Scars
  • Contractures

Based on the treatment, the market is categorized as "surgical treatment" as follows:

  • Topical medication
  • Laser treatment
  • Cosmetic treatment
  • Surgical treatment
  • Injectable treatment

Furthermore, the scar treatment market is classified depending on the end-user type, i.e., hospital, private clinic, drug store, retail store, and e-commerce.

Geographically, the scar treatment market is best understood by categorizing it into five major regions and five major region-level markets, which are as follows:

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • Germany
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • Rest of Asia Pacific

Latin America Middle East, and Africa

  • Brazil
  • Mexico
  • rest of Latin America

Middle East and Africa

  • GCC
  • Rest of the Middle East and Africa

This study presents the market size and forecast for each considered geographical market for the period 2015-2025, as well as CAGRs for the forecast period 2017-2025, and is further cross-sectional presented in terms of scar type, treatment type, end-user type, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global scar treatment market. Competition assessment tools such as major agreements, partnerships, and collaborations, market attractiveness assessment, and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the scar treatment market. The key players profiled in this report are Smith & Nephew plc, Lumenis, Sonoma Pharmaceuticals, Inc., Scarheal Inc., CCA Industries, Inc., Cynosure, Inc., Syneron Medical Ltd., Mölnlycke Health Care AB, Beijing Toplaser Technology Company Ltd., Merz GMBH & Co KGAA, Valeant Pharmaceuticals International Inc., Quantum Health, Hologic Inc., and others.

Scars are typical of the recuperating process; therefore, normal scars are not treated. Just when shallow scars turn out to be cosmetically unwanted or potentially harmful, they require treatment. Scars are quite often analyzed by visual investigation. There are several unusual circumstances in which it may be necessary to examine scar tissue under a microscope in order to confirm its true nature or to properly diagnose it by biopsy.

Based on the types of treatment for scars, the market can be classified as follows:

Topical medication

  • Oil
  • Gel
  • Ointment
  • silicone gel sheet
  • Cream

Laser treatment

Cosmetic treatment

  • Cryosurgery
  • Chemical Peeling
  • Dermabrasion

Surgical treatment

  • Skin grafts
  • Z-plastic
  • Skin Flap

Injectable treatment

The topical medicine segment can be classified as oil, gel, ointment, silicone gel sheet, and cream. This segment is expected to experience exponential growth in the near future due to its cost-effectiveness, ease of application, and easy availability.

Although the laser treatment is a bit expensive, the faster and more effective laser treatment provides better results with very little recovery time. These advantages contribute to the much higher adoption of ablative, fractionated, and non-ablative lasers for scar treatment. Cosmetic treatments can be classified as cryosurgery, chemical peeling, and dermabrasion. These procedures give rise to smoother skin by eliminating the top layer of skin.

Skin grafts, Z-plastic, and skin flaps are some of the surgical procedures that involve incisions for removing scar tissues; however, the high cost and chances of the formation of additional scars restrain the growth of surgical procedures, and henceforth the preference is expected to decrease in the upcoming years.

Steroids, collagen, and other fillers can be injected to obtain smooth skin by eliminating inflammation. This is a temporary solution that needs repeated treatment. This segment is growing due to the immediate visible result, rare side effects, and shorter time process.

A scar is developed on the skin during the body's wound-healing process. The smaller scars usually heal on their own, but the larger one requires medical attention. The area where the scar evolves is associated with itchiness, pain, redness, and irritation. The differences among the scars are due to variations in size, shape, and texture.

The segmentation of scars is as follows:

  • Atrophic Scars
  • Keloid Scars
  • Hypertrophic Scars
  • Contractures

Hypertrophic is the most common type of scar with a raised pattern that is not characterized by any malignancy and gets resolved on its own, whereas keloids are much larger in size, elevated in shape, and can be developed in any part of the body where there is any injury. Keloids are anticipated to affect both sexes and normally evolve from insect bites, surgical incisions, burns, or any injury. Dark-skinned people are more prone to keloids. Atrophic scars are associated with skin diseases, mostly acne, and they are flat in shape. The cause of a contracture scar is a burn, which limits motion because the skin and surrounding tissue force together while healing.

As per a research study, acne is supposed to be the eighth most prevalent disease around the globe due to changing lifestyles, an improper diet, excessive stress, and hormonal imbalance. Acne treatment encompasses a wide range of medical applications, ranging from surgical incisions to cosmetic procedures to topical medicine. Therefore, the atrophic scar segment is expected to dominate the scar treatment market. Public health awareness, physical appearance consciousness, and healthcare expenditure increase the number of surgical procedures in developed countries, resulting in significant growth in the scar treatment market. Keloids may turn out to generate serious complications at a later stage, so early treatment is preferred, and the recent development of technologically advanced medical devices or the pharmaceutical industry has contributed to the growth of the scar treatment market.

A scar is an appearance of the skin's healing procedure. Scars can be the result of any surgical procedure (burn, injury, etc.), which can involve the application of various medical technologies.

Depending on the end-user types, the scar treatment market has been segmented as follows:

  • Hospital care
  • Private Clinics
  • Drugstore or retail store
  • E-commerce

The hospital segment dominates the scar treatment market in terms of market share, followed by private clinics, and the reason behind it is the usage of topical care medicines, laser operations, and surgical incisions that are mostly performed in hospitals. The increasing trend of cosmetic procedures performed in private clinics is boosting the growth of the clinic segment, which is estimated to face lucrative growth in the near future. Moreover, the easy availability and lucrative discount option on topical medications from a retail drug store or from e-commerce are boosting the significant growth in these segments.

Geographically, the global scar treatment market is cumulative for North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.

North America is predicted to have the largest share of the scar treatment market, followed by Europe. According to the American Society of Plastic Surgeons, around 181,000 scar revision procedures were performed in the year 2016, which was an increase of 1% from 2015. This increasing trend of scar revision procedures, along with the highest expenses in personal care products, rising aging problems, increased awareness about improved physical appearance, the growing adoption rate of technologically advanced procedures and products, and regulatory approval of various products, are a few of the factors that drive the scar treatment market largely in these regions. The huge number of people suffering from skin disease and the developing healthcare infrastructure fuel the growth of the scar treatment market in Asia-Pacific, and it is expected to face substantial growth in upcoming periods due to the growing trend of consumer awareness.

The detailed regional classification of the global scar treatment market is as follows:

  • North America (U.S. and Canada)
  • Europe (Germany, U.K., France, Spain, Italy, and the Rest of Europe)
  • Asia Pacific (China, India, Japan, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East and Africa (GCC plus the rest of the Middle East and Africa) 

Frequently Asked Question:

The market for Scar Treatment Market is expected to reach USD$ 35.0 Bn in 2025.

The Scar Treatment Market is expected to see significant CAGR growth over the coming years, at 9.5%

The report is forecasted from 2017 -2025.

The base year of this report is 2016.

Smith & Nephew plc, Lumenis, Sonoma Pharmaceuticals, Inc., Scarheal Inc., CCA Industries, Inc., Cynosure, Inc., Syneron Medical Ltd., Mölnlycke Health Care AB. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Sep 2017
Category:  Medical Devices
Report ID:   58671
Report Format:   PDF
Pages:   120
Rating:    4.7 (65)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support